A pragmatic clinicopathobiological grouping/staging system for gliomas

Proposal of the Indian TNM subcommittee on brain tumors

Tejpal Gupta, Rajiv Sarin, Rakesh Jalali, Suash Sharma, Purna Kurkure, Atul Goel

Research output: Contribution to journalArticle

Abstract

Background: There is no universally accepted staging system for primary brain tumors wherein prognostication is mainly based on complex composite indices. Aim: To develop a simple, pragmatic, and widely applicable grouping/staging system for gliomas, the most common primary brain tumor. Materials and Methods: An expert neurooncology panel with representation from radiation oncology, neurosurgery, pathology, radiology, and medical oncology had several rounds of discussion on issues pertinent to brain tumor staging. The trade off was between the accuracy of prognostic categorization and a pragmatic, widely applicable approach. Results and Recommendations: The Tumor-Node-Metastasis staging was considered irrelevant for gliomas that seldom metastasize to lymphatics or outside the neuraxis. Instead, a 4-point staging/grouping system is proposed, using histological grade as the main prognostic variable and at least one stage migration based on other unfavorable features such as tumor location (brainstem); age (< 5 years for all grades, >50 years for high-grade, and >40 years for low-grade gliomas); poor neurological performance status (NPS 2-4); multicentricity and/or gliomatosis; and adverse biological parameters (proliferative index, angiogenesis markers, apoptotic index, cytogenetic abnormalities, and molecular markers). Conclusion: In absence of a grouping/staging system for primary brain tumors, prognostification is mostly based on complex composite indices. The proposed clinicopathobiological grouping/staging system for gliomas is a simple, pragmatic, and user-friendly tool with a potential to fulfill the objectives of staging classification.

Original languageEnglish (US)
Pages (from-to)247-251
Number of pages5
JournalNeurology India
Volume57
Issue number3
DOIs
StatePublished - Jul 1 2009

Fingerprint

Brain Neoplasms
Glioma
Brain Stem Neoplasms
Radiation Oncology
Medical Oncology
Neoplasm Staging
Neurosurgery
Radiology
Chromosome Aberrations
Pathology
Neoplasm Metastasis
Neoplasms

Keywords

  • Gliomas
  • Prognosis
  • Staging classification

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

A pragmatic clinicopathobiological grouping/staging system for gliomas : Proposal of the Indian TNM subcommittee on brain tumors. / Gupta, Tejpal; Sarin, Rajiv; Jalali, Rakesh; Sharma, Suash; Kurkure, Purna; Goel, Atul.

In: Neurology India, Vol. 57, No. 3, 01.07.2009, p. 247-251.

Research output: Contribution to journalArticle

Gupta, Tejpal ; Sarin, Rajiv ; Jalali, Rakesh ; Sharma, Suash ; Kurkure, Purna ; Goel, Atul. / A pragmatic clinicopathobiological grouping/staging system for gliomas : Proposal of the Indian TNM subcommittee on brain tumors. In: Neurology India. 2009 ; Vol. 57, No. 3. pp. 247-251.
@article{4ebe5281e06d49569623d48f957552d9,
title = "A pragmatic clinicopathobiological grouping/staging system for gliomas: Proposal of the Indian TNM subcommittee on brain tumors",
abstract = "Background: There is no universally accepted staging system for primary brain tumors wherein prognostication is mainly based on complex composite indices. Aim: To develop a simple, pragmatic, and widely applicable grouping/staging system for gliomas, the most common primary brain tumor. Materials and Methods: An expert neurooncology panel with representation from radiation oncology, neurosurgery, pathology, radiology, and medical oncology had several rounds of discussion on issues pertinent to brain tumor staging. The trade off was between the accuracy of prognostic categorization and a pragmatic, widely applicable approach. Results and Recommendations: The Tumor-Node-Metastasis staging was considered irrelevant for gliomas that seldom metastasize to lymphatics or outside the neuraxis. Instead, a 4-point staging/grouping system is proposed, using histological grade as the main prognostic variable and at least one stage migration based on other unfavorable features such as tumor location (brainstem); age (< 5 years for all grades, >50 years for high-grade, and >40 years for low-grade gliomas); poor neurological performance status (NPS 2-4); multicentricity and/or gliomatosis; and adverse biological parameters (proliferative index, angiogenesis markers, apoptotic index, cytogenetic abnormalities, and molecular markers). Conclusion: In absence of a grouping/staging system for primary brain tumors, prognostification is mostly based on complex composite indices. The proposed clinicopathobiological grouping/staging system for gliomas is a simple, pragmatic, and user-friendly tool with a potential to fulfill the objectives of staging classification.",
keywords = "Gliomas, Prognosis, Staging classification",
author = "Tejpal Gupta and Rajiv Sarin and Rakesh Jalali and Suash Sharma and Purna Kurkure and Atul Goel",
year = "2009",
month = "7",
day = "1",
doi = "10.4103/0028-3886.53261",
language = "English (US)",
volume = "57",
pages = "247--251",
journal = "Neurology India",
issn = "0028-3886",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

TY - JOUR

T1 - A pragmatic clinicopathobiological grouping/staging system for gliomas

T2 - Proposal of the Indian TNM subcommittee on brain tumors

AU - Gupta, Tejpal

AU - Sarin, Rajiv

AU - Jalali, Rakesh

AU - Sharma, Suash

AU - Kurkure, Purna

AU - Goel, Atul

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Background: There is no universally accepted staging system for primary brain tumors wherein prognostication is mainly based on complex composite indices. Aim: To develop a simple, pragmatic, and widely applicable grouping/staging system for gliomas, the most common primary brain tumor. Materials and Methods: An expert neurooncology panel with representation from radiation oncology, neurosurgery, pathology, radiology, and medical oncology had several rounds of discussion on issues pertinent to brain tumor staging. The trade off was between the accuracy of prognostic categorization and a pragmatic, widely applicable approach. Results and Recommendations: The Tumor-Node-Metastasis staging was considered irrelevant for gliomas that seldom metastasize to lymphatics or outside the neuraxis. Instead, a 4-point staging/grouping system is proposed, using histological grade as the main prognostic variable and at least one stage migration based on other unfavorable features such as tumor location (brainstem); age (< 5 years for all grades, >50 years for high-grade, and >40 years for low-grade gliomas); poor neurological performance status (NPS 2-4); multicentricity and/or gliomatosis; and adverse biological parameters (proliferative index, angiogenesis markers, apoptotic index, cytogenetic abnormalities, and molecular markers). Conclusion: In absence of a grouping/staging system for primary brain tumors, prognostification is mostly based on complex composite indices. The proposed clinicopathobiological grouping/staging system for gliomas is a simple, pragmatic, and user-friendly tool with a potential to fulfill the objectives of staging classification.

AB - Background: There is no universally accepted staging system for primary brain tumors wherein prognostication is mainly based on complex composite indices. Aim: To develop a simple, pragmatic, and widely applicable grouping/staging system for gliomas, the most common primary brain tumor. Materials and Methods: An expert neurooncology panel with representation from radiation oncology, neurosurgery, pathology, radiology, and medical oncology had several rounds of discussion on issues pertinent to brain tumor staging. The trade off was between the accuracy of prognostic categorization and a pragmatic, widely applicable approach. Results and Recommendations: The Tumor-Node-Metastasis staging was considered irrelevant for gliomas that seldom metastasize to lymphatics or outside the neuraxis. Instead, a 4-point staging/grouping system is proposed, using histological grade as the main prognostic variable and at least one stage migration based on other unfavorable features such as tumor location (brainstem); age (< 5 years for all grades, >50 years for high-grade, and >40 years for low-grade gliomas); poor neurological performance status (NPS 2-4); multicentricity and/or gliomatosis; and adverse biological parameters (proliferative index, angiogenesis markers, apoptotic index, cytogenetic abnormalities, and molecular markers). Conclusion: In absence of a grouping/staging system for primary brain tumors, prognostification is mostly based on complex composite indices. The proposed clinicopathobiological grouping/staging system for gliomas is a simple, pragmatic, and user-friendly tool with a potential to fulfill the objectives of staging classification.

KW - Gliomas

KW - Prognosis

KW - Staging classification

UR - http://www.scopus.com/inward/record.url?scp=67651174575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651174575&partnerID=8YFLogxK

U2 - 10.4103/0028-3886.53261

DO - 10.4103/0028-3886.53261

M3 - Article

VL - 57

SP - 247

EP - 251

JO - Neurology India

JF - Neurology India

SN - 0028-3886

IS - 3

ER -